Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1985 Jul;49(1):212–218. doi: 10.1128/iai.49.1.212-218.1985

Antimicrobial activities of dialysate-elicited and resident human peritoneal macrophages.

P K Peterson, E Gaziano, H J Suh, M Devalon, L Peterson, W F Keane
PMCID: PMC262081  PMID: 3159679

Abstract

Recent studies of the antimicrobial capacity of peritoneal macrophages (PM phi) isolated from patients undergoing chronic peritoneal dialysis have raised the question of whether these cells might be analogous to stimulated or activated murine PM phi. To explore this possibility, we compared PM phi from these patients (dialysate-elicited PM phi) with PM phi obtained from women undergoing laparoscopy (resident PM phi) in several in vitro assays of phagocyte function. Although bacterial phagocytosis by cells from both groups of donors was similar, significant differences were found in their chemiluminescence responses to opsonized zymosan. Although the mean peak luminol-enhanced chemiluminescence response of dialysate-elicited PM phi was 4.7 X 10(5) cpm, that of resident PM phi was only 1.3 X 10(5) cpm (P less than 0.05). In a lucigenin-enhanced chemiluminescence assay, dialysate-elicited PM phi again generated significantly greater chemiluminescence than did resident PM phi, suggesting that dialysate-elicited PM phi have a relatively increased capacity for O2- production. Using a fluorochrome microassay to assess the intracellular candidicidal activities of these cells, we found that dialysate-elicited PM phi killed 17% of cell-associated blastospores compared with only 1.5% killing by resident PM phi (P less than 0.05). These investigations led us to conclude that results of studies of the functional activity of dialysate-elicited PM phi cannot necessarily be extrapolated to resident PM phi and that dialysate-elicited PM phi do in some respects behave as stimulated or activated cells.

Full text

PDF
212

Images in this article

215Image
on p.215

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ackerman S. K., Douglas S. D. Purification of human monocytes on microexudate-coated surfaces. J Immunol. 1978 Apr;120(4):1372–1374. [PubMed] [Google Scholar]
  2. Allen R. C., Loose L. D. Phagocytic activation of a luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages. Biochem Biophys Res Commun. 1976 Mar 8;69(1):245–252. doi: 10.1016/s0006-291x(76)80299-9. [DOI] [PubMed] [Google Scholar]
  3. Arenson E. B., Jr, Epstein M. B., Seeger R. C. Volumetric and functional heterogeneity of human monocytes. J Clin Invest. 1980 Mar;65(3):613–618. doi: 10.1172/JCI109706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beelen R. H., Fluitsma D. M. What is the relevance of exudate-resident macrophages? Immunobiology. 1982 Apr;161(3-4):266–273. doi: 10.1016/S0171-2985(82)80082-X. [DOI] [PubMed] [Google Scholar]
  5. Bianco C., Griffin F. M., Jr, Silverstein S. C. Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation. J Exp Med. 1975 Jun 1;141(6):1278–1290. doi: 10.1084/jem.141.6.1278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Breton-Gorius J., Reyes F., Duhamel G., Najman A., Gorin N. C. Megakaryoblastic acute leukemia: identification by the ultrastructural demonstration of platelet peroxidase. Blood. 1978 Jan;51(1):45–60. [PubMed] [Google Scholar]
  7. Cohn Z. A. Activation of mononuclear phagocytes: fact, fancy, and future. J Immunol. 1978 Sep;121(3):813–816. [PubMed] [Google Scholar]
  8. Daems W. T., de Bakker J. M. Do resident macrophages proliferate? Immunobiology. 1982 Apr;161(3-4):204–211. doi: 10.1016/S0171-2985(82)80075-2. [DOI] [PubMed] [Google Scholar]
  9. Dahlgren C., Stendahl O. Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocytes. Infect Immun. 1983 Feb;39(2):736–741. doi: 10.1128/iai.39.2.736-741.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. DeChatelet L. R., Long G. D., Shirley P. S., Bass D. A., Thomas M. J., Henderson F. W., Cohen M. S. Mechanism of the luminol-dependent chemiluminescence of human neutrophils. J Immunol. 1982 Oct;129(4):1589–1593. [PubMed] [Google Scholar]
  11. Diamond R. D., Clark R. A., Haudenschild C. C. Damage to Candida albicans hyphae and pseudohyphae by the myeloperoxidase system and oxidative products of neutrophil metabolism in vitro. J Clin Invest. 1980 Nov;66(5):908–917. doi: 10.1172/JCI109958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Edelson P. J. Intracellular parasites and phagocytic cells: cell biology and pathophysiology. Rev Infect Dis. 1982 Jan-Feb;4(1):124–135. doi: 10.1093/clinids/4.1.124. [DOI] [PubMed] [Google Scholar]
  13. Ezekowitz R. A., Gordon S. Alterations of surface properties by macrophage activation: expression of receptors for Fc and mannose-terminal glycoproteins and differentiation antigens. Contemp Top Immunobiol. 1984;13:33–56. doi: 10.1007/978-1-4757-1445-6_2. [DOI] [PubMed] [Google Scholar]
  14. Griffin F. M., Jr, Mullinax P. J. Augmentation of macrophage complement receptor function in vitro. III. C3b receptors that promote phagocytosis migrate within the plane of the macrophage plasma membrane. J Exp Med. 1981 Aug 1;154(2):291–305. doi: 10.1084/jem.154.2.291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hahn H., Kaufmann S. H. The role of cell-mediated immunity in bacterial infections. Rev Infect Dis. 1981 Nov-Dec;3(6):1221–1250. doi: 10.1093/clinids/3.6.1221. [DOI] [PubMed] [Google Scholar]
  16. Halme J., Becker S., Wing R. Accentuated cyclic activation of peritoneal macrophages in patients with endometriosis. Am J Obstet Gynecol. 1984 Jan 1;148(1):85–90. doi: 10.1016/s0002-9378(84)80037-x. [DOI] [PubMed] [Google Scholar]
  17. Hoidal J. R., Schmeling D., Peterson P. K. Phagocytosis, bacterial killing, and metabolism by purified human lung phagocytes. J Infect Dis. 1981 Jul;144(1):61–71. doi: 10.1093/infdis/144.1.61. [DOI] [PubMed] [Google Scholar]
  18. Horwitz M. A., Silverstein S. C. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. J Clin Invest. 1980 Jan;65(1):82–94. doi: 10.1172/JCI109663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Johnston R. B., Jr Oxygen metabolism and the microbicidal activity of macrophages. Fed Proc. 1978 Nov;37(13):2759–2764. [PubMed] [Google Scholar]
  20. KAPLOW L. S. SIMPLIFIED MYELOPEROXIDASE STAIN USING BENZIDINE DIHYDROCHLORIDE. Blood. 1965 Aug;26:215–219. [PubMed] [Google Scholar]
  21. Karnovsky M. L., Lazdins J. K. Biochemical criteria for activated macrophages. J Immunol. 1978 Sep;121(3):809–813. [PubMed] [Google Scholar]
  22. Keane W. F., Comty C. M., Verbrugh H. A., Peterson P. K. Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis. Kidney Int. 1984 Mar;25(3):539–543. doi: 10.1038/ki.1984.51. [DOI] [PubMed] [Google Scholar]
  23. Kim M. H., Rodey G. E., Good R. A., Chilgren R. A., Quie P. G. Defective candidacidal capacity of polymorphonuclear leukocytes in chronic granulomatous disease of childhood. J Pediatr. 1969 Aug;75(2):300–303. doi: 10.1016/s0022-3476(69)80403-8. [DOI] [PubMed] [Google Scholar]
  24. Lehrer R. I., Cline M. J. Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J Clin Invest. 1969 Aug;48(8):1478–1488. doi: 10.1172/JCI106114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. MACKANESS G. B. THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE. J Exp Med. 1964 Jul 1;120:105–120. doi: 10.1084/jem.120.1.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. MacGowan A. P., Peterson P. K., Keane W., Quie P. G. Human peritoneal macrophage phagocytic, killing, and chemiluminescent responses to opsonized Listeria monocytogenes. Infect Immun. 1983 Apr;40(1):440–443. doi: 10.1128/iai.40.1.440-443.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Murray H. W., Juangbhanich C. W., Nathan C. F., Cohn Z. A. Macrophage oxygen-dependent antimicrobial activity. II. The role of oxygen intermediates. J Exp Med. 1979 Oct 1;150(4):950–964. doi: 10.1084/jem.150.4.950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Nathan C. F., Root R. K. Hydrogen peroxide release from mouse peritoneal macrophages: dependence on sequential activation and triggering. J Exp Med. 1977 Dec 1;146(6):1648–1662. doi: 10.1084/jem.146.6.1648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Norris D. A., Morris R. M., Sanderson R. J., Kohler P. F. Isolation of functional subsets of human peripheral blood monocytes. J Immunol. 1979 Jul;123(1):166–172. [PubMed] [Google Scholar]
  30. North R. J. The concept of the activated macrophage. J Immunol. 1978 Sep;121(3):806–809. [PMC free article] [PubMed] [Google Scholar]
  31. Parry M. F., Root R. K., Metcalf J. A., Delaney K. K., Kaplow L. S., Richar W. J. Myeloperoxidase deficiency: prevalence and clinical significance. Ann Intern Med. 1981 Sep;95(3):293–301. doi: 10.7326/0003-4819-95-3-293. [DOI] [PubMed] [Google Scholar]
  32. Parwaresch M. R., Radzun H. J., Dommes M. The homogeneity and monocytic origin of human peritoneal macrophages evidence by comparison of esterase polymorphism. Am J Pathol. 1981 Feb;102(2):209–218. [PMC free article] [PubMed] [Google Scholar]
  33. Peterson P. K., Gekker G., Shapiro R., Freiberg M., Keane W. F. Polyamino acid enhancement of bacterial phagocytosis by human polymorphonuclear leukocytes and peritoneal macrophages. Infect Immun. 1984 Feb;43(2):561–566. doi: 10.1128/iai.43.2.561-566.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Peterson P. K., Keane W. F., Miller W., Freiberg M., Staub D., Verbrugh H. A. Human peritoneal macrophage cytotoxicity mediated by cytophilic IgG. J Infect Dis. 1983 Dec;148(6):1040–1048. doi: 10.1093/infdis/148.6.1040. [DOI] [PubMed] [Google Scholar]
  35. Richards S. W., Peterson P. K., Verbrugh H. A., Nelson R. D., Hammerschmidt D. E., Hoidal J. R. Chemotactic and phagocytic responses of human alveolar macrophages to activated complement components. Infect Immun. 1984 Feb;43(2):775–778. doi: 10.1128/iai.43.2.775-778.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sasada M., Johnston R. B., Jr Macrophage microbicidal activity. Correlation between phagocytosis-associated oxidative metabolism and the killing of Candida by macrophages. J Exp Med. 1980 Jul 1;152(1):85–98. doi: 10.1084/jem.152.1.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Schleupner C. J., Glasgow L. A. Peritoneal macrophage activation indicated by enhanced chemiluminescence. Infect Immun. 1978 Sep;21(3):886–895. doi: 10.1128/iai.21.3.886-895.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Schuit K. E. Phagocytosis and intracellular killing of pathogenic yeasts by human monocytes and neutrophils. Infect Immun. 1979 Jun;24(3):932–938. doi: 10.1128/iai.24.3.932-938.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Verbrugh H. A., Hoidal J. R., Nguyen B. Y., Verhoef J., Quie P. G., Peterson P. K. Human alveolar macrophage cytophilic immunoglobulin G-mediated phagocytosis of protein A-positive staphylococci. J Clin Invest. 1982 Jan;69(1):63–74. doi: 10.1172/JCI110442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Verbrugh H. A., Keane W. F., Hoidal J. R., Freiberg M. R., Elliott G. R., Peterson P. K. Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysis. J Infect Dis. 1983 Jun;147(6):1018–1029. doi: 10.1093/infdis/147.6.1018. [DOI] [PubMed] [Google Scholar]
  41. Wallenstein S., Zucker C. L., Fleiss J. L. Some statistical methods useful in circulation research. Circ Res. 1980 Jul;47(1):1–9. doi: 10.1161/01.res.47.1.1. [DOI] [PubMed] [Google Scholar]
  42. Williams A. J., Cole P. J. Human bronchoalveolar lavage cells and luminol-dependent chemiluminescence. J Clin Pathol. 1981 Feb;34(2):167–171. doi: 10.1136/jcp.34.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Yam L. T., Li C. Y., Crosby W. H. Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol. 1971 Mar;55(3):283–290. doi: 10.1093/ajcp/55.3.283. [DOI] [PubMed] [Google Scholar]
  44. van Furth R. Current view on the mononuclear phagocyte system. Immunobiology. 1982 Apr;161(3-4):178–185. doi: 10.1016/S0171-2985(82)80072-7. [DOI] [PubMed] [Google Scholar]
  45. van Furth R., Hirsch J. G., Fedorko M. E. Morphology and peroxidase cytochemistry of mouse promonocytes, monocytes, and macrophages. J Exp Med. 1970 Oct 1;132(4):794–812. doi: 10.1084/jem.132.4.794. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES